Arnre Kristian Skulberg (Arne Kristian Skulberg)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Addiction (Abingdon, England)

BMC emergency medicine

European journal of clinical pharmacology

BMJ open

NTNU Det Medisinske Fakultet DMF

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NTNU Det Medisinske Fakultet DMF

Norway

post doctoral fellow :: Department of Circulation and Medical Imaging

Oslo universitetssykehus Ullevål

Norway

Consultant in Anaesthesia :: Division of Emergencies and Critical Care, Department of Anaesthesiology

Publications

Desiree Madah-Amiri, Linn Gjersing, Aksel Wüsthoff Danielsen, Arnre Kristian Skulberg, Ola Dale, Anne-Catherine Braarud, Fridtjof Heyerdahl, Ida Tylleskär
Heightened mortality risk after a non-fatal opioid overdose: Risk factors for mortality in the week following emergency treatment. Addiction (Abingdon, England) (2024)
Arnre Kristian Skulberg, Ida Tylleskär, Ola Dale
Naloxone administration-no balance without titration. Addiction (Abingdon, England) 117 (10) (2022)
Jostein Skjalg Hagemo, Arnre Kristian Skulberg, Marius Rehn, Morten Valberg, Maiju Pesonen, Hans Julius Heimdal, Fridtjof Heyerdahl
Inhaled nitric oxide as temporary respiratory stabilization in patients with COVID-19 related respiratory failure (INOCOV): Study protocol for a randomized controlled trial. PloS one 17 (5) (2022)
Arnre Kristian Skulberg, Ida Tylleskär, Morten Valberg, Anne-Cathrine Braarud, Jostein Dale, Fridtjof Heyerdahl, Tore Skålhegg, Jan Barstein, Sindre Mellesmo, Ola Dale
Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double-dummy, randomised, controlled trial. Addiction (Abingdon, England) 117 (6) (2022)
Ida Tylleskär, Sissel Skarra, Arnre Kristian Skulberg, Ola Dale
The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteers. European journal of clinical pharmacology 77 (12) (2021)
Arnre Kristian Skulberg, Ida Tylleskär, Anne-Cathrine Braarud, Jostein Dale, Fridtjof Heyerdahl, Sindre Mellesmo, Morten Valberg, Ola Dale
NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use. BMJ open 10 (11) (2020)
Ida Tylleskär, Linn Gjersing, Lars Petter Bjørnsen, Anne-Cathrine Braarud, Fridtjof Heyerdahl, Ola Dale, Arnre Kristian Skulberg
Prehospital naloxone administration - what influences choice of dose and route of administration? BMC emergency medicine 20 (1) (2020)
Arnre Kristian Skulberg, Anders Åsberg, Hasse Zare Khiabani, Hilde Røstad, Ida Tylleskar, Ola Dale
Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose-a randomized controlled trial. Addiction (Abingdon, England) 114 (5) (2019)

Arnre Kristian Skulberg.css-eqlu8i{font-size:small;padding-left:4px;} (Arne Kristian Skulberg)

Publication Activity (10 Years)

Top Topics

Top Venues

Arnre Kristian Skulberg (Arne Kristian Skulberg)